Andrographis paniculata or favipiravir in Mild COVID-19: A randomized control trial

Andrographis paniculata or favipiravir in Mild COVID-19: A randomized control trial

Background: The COVID-19 pandemic led to an urgent search for effective treatments. Andrographis paniculata (AP), a traditional herbal medicine, has shown potential due to its antiviral and anti-inflammatory properties. This study aimed to compare the efficacy and safety of AP capsules with favipira...

Full description

Saved in:
Bibliographic Details
Main Authors: Rujipas Sirijatuphat, Navin Horthongkham, Chutikarn Chaimayo, Patimaporn Wongprompitak, Wuttikrai Kongsankum, Phornnapa Charoenkij, Titchaphorn Palo, Suthatip Mahajaroensiri, Nalinthika Nathananwanit, Sansanee Senawong, Wannee Kantakamalakul, Pravit Akarasereenont, Chairat Permpikul
Format: Article
Language:English
Published: Elsevier 2025-08-01
Series:Phytomedicine Plus
Subjects:
Andrographis paniculata
favipiravir
COVID-19
traditional herbal medicine
symptom relief
pneumonia
Online Access:http://www.sciencedirect.com/science/article/pii/S2667031325001290
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2667031325001290

Similar Items